Leadercare
CLOSE X

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

As on Jun-24-2022 change fund
17.97  up0.06 (0.34%)

fund objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2018-20192019-20202020-20212021-2022
NAV in Rs (as on 31-Mar-2022)10.149.5417.3519.69
Net Assets(Rs Crores) (as on 31-Mar-2022) 1497.55 1073.47 2213.63 2500.42
Scheme Returns(%)(Absolute)1.40-6.3883.7912.51
B'mark Returns(%)(Absolute)7.46-15.0279.0813.52
Category Rank37/7315/7519/7547/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2021-202217.814.01-1.46-6.01
2020-202137.1122.3210.75-2.09
2019-2020-4.93-2.399.88-7.74
2018-2019NANA-5.362.63
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...12.92 
Lupin Ltd.7.79 
Dr. Reddy's Laboratories Ltd.7.75 
Alkem Laboratories Ltd.5.65 
Sanofi India Ltd.5.03 
Cipla Ltd.4.66 
Aster DM Healthcare Ltd.4.31 
Aurobindo Pharma Ltd.4.04 
SBI Life Insurance Company Ltd.3.64 
Indoco Remedies Ltd.3.61 

Category

Sector Funds

Launch Date

13-Jul-18

ISIN Code

INF109KC1GE9

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

2,316.08

portfolio price to book value

4.53

investing style?

Mid Growth

fund manager?

Dharmesh Kakkad,Priyanka Khandelwal

inception date (regular plan)

13-Jul-18

expense ratio (regular plan) %

2.14

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs73.91
Hospital & Healthcare Services13.21
Insurance5.67
Miscellaneous0.36

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20182,316.08-10.2823.78NANA15.99
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,691.61-7.1626.62NANA19.13
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,178.57-9.2225.81NANA20.28
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,515.92-12.3723.2715.4716.3419.79
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,638.30-10.4923.1110.0615.1014.75
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015508.15-7.4521.8512.33NA6.90
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005706.49-12.1121.4911.0413.1816.90
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201962.33-12.7618.40NANA15.51
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019470.26-10.68NANANA17.95
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021158.90NANANANA-13.62
ENTRY LOAD / EXIT LOAD
Max Entry Load [%]
0.00
Entry Remark
Max Exit Load [%]
1.00
Exit Remark
1% on or before 15D, Nil after 15D
52 Week Highs & Lows
52 Week High
21.65
52 Week Low
17.60
portfolio characteristics
As on 31-May-2022
Average Maturity
N.A
Modified Duration
N.A
Yield to Maturity
N.A.
Portfolio Turnover Ratio
0.44 Times
ratios
Statistical Ratios
Standard Deviation [%]
17.9988
Semi Standard Deviation [%]
0.6849
Beta [%]
0.5602
Sharp Ratio [%]
-0.3113
R-Square [%]
0.6472
Expense Ratio [%]
2.1400
AVG Ratio [%]
0.0072
Other Ratios
Jenson Ratio [%]
-0.0484
Treynor Ratio [%]
-0.0902
Turnover Ratio [%]
44.0000
FAMA Ratio [%]
-0.0484
SORTINO Ratio [%]
-0.0055
HEAD OFFICE Leader Care A-507/8 Navratna Corporate Park, Ashok Vatika Bopal-Ambli Road, Ahmedabad-380058
DISCLAIMER

Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objective of the Scheme will be achieved. Past performance of the Sponsor/AMC/Fund or that of any scheme of the Fund does not indicate the future performance of the Schemes of the Fund. Please read the Key Information Memorandum and the Offer Document carefully before investing.

  • INSURANCE DISCLAIMER - Insurance is a subject matter of solicitation
  • ARN Number - 11439
  • IRDAI Licence Number - AGQ0127782

Copyright © 2019Leader CareAll rights reserved

Designed, Developed & Content Powered by Accord Fintech Pvt. Ltd.